Moderna: Vaccine study shows ‘strong’ immune response in kids under 12
ROCHESTER, N.Y. (WHEC)— Moderna’s COVID-19-19 vaccine is showing a "strong" immune response in children under 12 years old, the company announced Monday.
The results are based off the second phase of a three-phase vaccine trial that’s pooling information from more than 4,750 children. While more specific results were not announced Monday, Modena reports the immune response in kids showed to be about 1.5% higher than in adults who received the vaccine.
This is based on a response one month after getting the second shot. The New York Times reports kids received about half the dosage of an adult vaccine in each shot.
The most common side effects were fatigue, headache, fever, and injection pain.
The company will submit its finding to be peer-reviewed. It comes as the Food and Drug Administration begins talks to possibly grant Emergency Use Authorization for kid-sized doses of Pfizer’s vaccine, which was shown to be 91% effective.